Table III.
Outcome | Rate before COVID-19 (mean [SE])‡ | Rate during COVID-19 (mean [SE])‡ | Ratio of rates before vs during COVID-19 (95% confidence interval) | P |
---|---|---|---|---|
All exacerbations∗ | 0.264 (0.009) | 0.214 (0.009) | 0.810 (0.739-0.888) | <.001 |
Prednisone∗ | 0.213 (0.008) | 0.169 (0.008) | 0.794 (0.718-0.878) | <.001 |
Any inpatient visit† | 0.004 (0.001) | 0.002 (0.001) | 0.478 (0.238-0.960) | .04 |
Any emergency department visit† | 0.017 (0.002) | 0.015 (0.002) | 0.874 (0.650-1.175) | .37 |
Any urgent care visit† | 0.025 (0.002) | 0.023 (0.002) | 0.903 (0.717-1.137) | .39 |
Portion of days covered∗ | 0.528 (0.004) | 0.539 (0.004) | 1.022 (1.010-1.033) | <.001 |
Asthma medication ratio§ | 0.755 (0.003) | 0.762 (0.003) | 1.035 (1.006-1.064) | .019 |
Poisson model accounting for repeated measures unadjusted for covariates. The ratio with the confidence interval is the incidence density ratio.
Generalized linear model using log-binomial model accounting for repeated measures unadjusted for covariates. The reported ratio and confidence interval are the relative risk.
Rates are adjusted for person-years except for the asthma medication ratio, which is not dependent on time.
Odds ratio for logit model with fractional-dependent variable accounting for repeated measures.